Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](CStone Pharmaceuticals)"
Count: 27
Selected: 0
| NCT ID | Title |
|---|
| NCT04254939 | A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor | ||
| NCT04194801 | A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma | ||
| NCT05700448 | Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma | ||
| NCT05381753 | Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real World | ||
| NCT05297890 | A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer | ||
| NCT05279300 | A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas | ||
| NCT04421352 | Safety and Tolerability Evaluation of Low-dose Radiation in Combination With CS1001 in Relapsed SCLC Patients | ||
| NCT04338724 | A Phase I Study of CS1002 in Subjects With Advanced Solid Tumors | ||
| NCT04233060 | A Study of CS3005 in Advanced Solid Tumors | ||
| NCT04200404 | A Study of CS1001 in Combination With Regorafenib in Patients With Advanced or Refractory Solid Tumors | ||
| NCT04194775 | A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma | ||
| NCT04187352 | A Study of CS1001 in Subjects With Esophageal Squamous Cell Carcinoma | ||
| NCT04176393 | A China Bridging Study of Ivosidenib in r/r AML Subjects With an IDH1 Mutation | ||
| NCT04162301 | A Study of CS3002 in Subjects With Advanced Solid Tumors | ||
| NCT03809767 | A Study of CS1003 in Subjects With Advanced Solid Tumors or Lymphomas | ||
| NCT03802591 | A Study of CS1001 in Subjects With Gastric Adenocarcinoma or Gastro-Esophageal Junction Adenocarcinoma | ||
| NCT03789604 | A Study of CS1001 in Subjects With Stage IV Non-Small Cell Lung Cancer | ||
| NCT03744403 | A Study of CS1001 in Subjects With Advanced Solid Tumors | ||
| NCT03736850 | Study of CS3006 in Subjects With Locally Advanced or Metastatic Solid Tumors | ||
| NCT03728556 | A Study of CS1001 in Subjects With Stage III Non-Small Cell Lung Cancer | ||
| NCT03595657 | A Study of CS1001 in Subjects With Relapsed or Refractory Extranodal Natural Killer/ T Cell Lymphoma(ENKTL) | ||
| NCT03523819 | A Study of CS1002 in Subjects With Advanced Solid Tumors | ||
| NCT03516123 | A Study of CS3006 in Subjects With Locally Advanced or Metastatic Solid Tumors | ||
| NCT03505996 | A Study of CS1001 in Subjects With Relapsed or Refractory Classical Hodgkin Lymphoma | ||
| NCT03475251 | A Study of CS1003 in Subjects With Advanced Solid Tumors | ||
| NCT03312842 | A Phase Ia/Ib Study of CS1001 in Subjects With Advanced Solid Tumors | ||
| NCT04472858 | A Study of CS1001 in Combination With Donafenib in Subjects With Advanced Solid Tumors |
